CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 83 enrolled
Drug / intervention
Exercise Programbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02367092
NCT02367092N/ACompleted
CompareCT.gov

Exercise Intervention in Liver Transplant Patients

University of California, San Francisco·interventional·Posted Feb 20, 2015·Updated Sep 7, 2022

In Brief

A clinical study evaluating Exercise Program for End Stage Liver Disease and 2 related conditions. Completed, enrolled 83 participants across 3 sites.

Detailed Summary

The purpose of this study is to learn more about the effects of exercise on functional status and outcomes on patients with end-stage liver disease on the liver transplant waiting list and who have undergone liver transplantation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEnd Stage Liver Disease, Sarcopenia, Liver Cirrhoses
CountriesUnited States
CollaboratorsJohns Hopkins University, Duke University

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedFeb 20, 2015
Enrollment StartJul 1, 2016
Primary CompletionDec 1, 2019
TodayJul 2, 2026
Enrollment to primary: 3.4 yearsPosted 11.4 years ago

Interventions

Exercise Programbehavioral

They will perform low-intensity, low-resistance exercise facilitated by a DVD video in their home. This exercise program lasts for 30 minutes at a time. Patients will be instructed to engage in this exercise program 3-4 times per week but not more often than 4 times per week. Pre-transplant patients will be asked to do the exercises from enrollment to transplant. Post-transplant patients will be asked to do the exercises for 6 months.